Figure 3

Flow chart depicting the subdivision of patients into relevant prognostic groups by classification regression tree analysis. MSMB expression was subdivided by intensity and subsequently by fraction of positive tumor cells into four groups with different risk for biochemical recurrence. For CRISP3 expression, no subgroups were significantly linked to outcome. Only patients with complete follow-up data were included (n=2460).